BioSpace News Archive

Business

Mereo and Rubric Settle Proxy Battle, Oust and Replace Board Members

Mereo and Rubric Capital Management settled their proxy battle, entering a cooperation agreement. As a result, Rubric withdrew its notice for a General Meeting of shareholders.

October 28, 2022
·
2 min read
·
Mark Terry
Gilead’s Hopes for HDV Approval Delayed after CRL

The FDA issued a Complete Response Letter regarding Gilead’s Biologics License Application for bulevirtide, citing concerns regarding the manufacture and delivery of the drug.

October 28, 2022
·
2 min read
·
Alex Keown
Business

How to Address a Layoff in Your Cover Letter

Being laid off from your job can be difficult and confusing. To help you in your job search, we’ve explained how to address a layoff in your cover letter to help you land your dream job.

October 28, 2022
·
4 min read
·
Franklin Carpenter
PTC Snags Up to $1B from Blackstone to Accelerate Pipeline

PTC Therapeutics forged a financing deal valued at up to $1 billion with Blackstone that will allow it to deliver one new therapy every two or three years, the New Jersey-based biotech reported.

October 28, 2022
·
3 min read
·
Alex Keown
Drug Development

Industry’s IL-2 Struggles Continue as Sanofi Drops Program

Sanofi will drop its IL-2 candidate, citing a lack of efficacy in the early stages of data collection, the company announced in its Q3 report Friday.

October 28, 2022
·
2 min read
·
Kaley Lefevre
Business

FDA Adcomm to Meet on BioMarin’s Hemophilia A Gene Therapy

During its third-quarter earnings report, BioMarin noted that the FDA planned to hold an advisory committee meeting to discuss the company’s gene therapy for hemophilia A.

October 28, 2022
·
2 min read
·
Mark Terry
Drug Development

Eisai Responds to Claims Linking Patient Death to Lecanemab (Updated)

An investigator in the Phase III trial for Biogen and Eisai’s experimental Alzhiemer’s drug, lecanemab, is attributing a patient’s death to the treatment.

October 28, 2022
·
2 min read
·
Heather McKenzie
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib

Pharming Group N.V. announces that its Marketing Authorisation Application for leniolisib has been validated for scientific evaluation under an accelerated assessment by the European Medicines Agency’s Committee for Medicinal Products for Human Use.

October 28, 2022
·
8 min read
SINOVAC to Showcase Products at CPHI Frankfurt

Sinovac Biotech Ltd. announced that the Company will participate in CPHI Frankfurt, one of the world’s largest pharmaceutical exhibitions, from 1st to 3rd of November, in Frankfurt, Germany.

October 28, 2022
·
2 min read
Business

RadNet, Inc. Announces Date of its Third Quarter 2022 Financial Results Conference Call

RadNet, Inc. announced that it will host a conference call to discuss its third quarter 2022 financial results on Wednesday, November 9th, 2022 at 7:30 a.m. Pacific Time.

October 28, 2022
·
1 min read